Compound Detail
CHEMBL5436635
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5436635 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | SNNQPXKBHJFXTJ-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
8
Publications
0
Known Names
Molecular Properties
447.5
MW (Da)
4.15
ALogP
5
HBA
2
HBD
97.8
PSA (Ų)
0.57
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 7.58
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Fatty-acid amide hydrolase 1 CHEMBL2243 | IC50 | 7.58 | 7.58 | 26.3 | 1 |
| NIH3T3 CHEMBL614822 | IC50 | 4.35 | 4.35 | 45000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Fatty-acid amide hydrolase 1 | IC50 | = | 26.3 | nM | 7.58 | Inhibition of human recombinant FAAH using AMC-AA as substrate preincubated for ... | 36462439 |
| NIH3T3 | IC50 | = | 45000.0 | nM | 4.35 | Cytotoxicity against mouse NIH3T3 cells assessed as inhibition of cell growth me... | 36462439 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36462439 | 10.1016/j.ejmech.2022.114952 | No relevant target | 5 |
| 36462439 | 10.1016/j.ejmech.2022.114952 | Fatty-acid amide hydrolase 1 | 2 |
| 36462439 | 10.1016/j.ejmech.2022.114952 | Hippocampus | 2 |
| 36462439 | 10.1016/j.ejmech.2022.114952 | Monoglyceride lipase | 1 |
| 36462439 | 10.1016/j.ejmech.2022.114952 | NIH3T3 | 1 |
| 36462439 | 10.1016/j.ejmech.2022.114952 | Cannabinoid receptor 1 | 1 |
| 36462439 | 10.1016/j.ejmech.2022.114952 | Cannabinoid receptor 2 | 1 |
| 36462439 | 10.1016/j.ejmech.2022.114952 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine